Author

Chandrasekhar Abbineni

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Susanta SamajdariD· 2 shared A B Aravind· 1 shared Andrej Coleski· 1 shared Arul M. ChinnaiyaniD· 1 shared Arushi SharmaiD· 1 shared Arvind Rao· 1 shared Debarka SenguptaiD· 1 shared Dinesh Chikkanna· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Susanta SamajdarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A druggable chromatin vulnerability in suppressive neutrophils restores antitumor immunity

Fan Yang, Yi Bao, Yuanyuan Qiao, Gabriel Cruz, Eleanor Young, Rahul Mannan, Yuping Zhang, Matt Goodrich, Yizhi Cao, Jie Luo, Radha Paturu, Somnath Mahapatra, Jean Ching-Yi Tien, Royce Xu, Mikoto Kobayashi, , Arul M. Chinnaiyan

This paper identifies a druggable chromatin vulnerability in suppressive neutrophils that can restore antitumor immunity through mSWI/SNF antagonists.

bioRxiv · Sep 28, 2026 · PreprintCancer Biology

SynGlue: AI-Driven Designer for Clinically Actionable Multi-Target Therapeutics

Saveena Solanki, Sanjay Kumar Mohanty, Shiva Satija, Sonam Chauhan, N.V.M. Rao Bandaru, Sandeep Dukare, Nirbhay Kumar Tiwari, R. Naveen Kumar, A B Aravind, Subhendu Mukherjee, Dinesh Chikkanna, Wesley Roy Balasubramanian, Srinivasa Raju Sammeta, Vishakha Gautam, Sakshi Arora, , Gaurav Ahuja

SynGlue is an AI framework that designs multi-target therapeutics by combining data-driven and structure-guided methods, producing potent degraders for BRD4 and GSPT1.

bioRxiv · Aug 28, 2025 · PreprintBioinformatics